The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

G. Merdzhanova,Stéphanie Gout,Michelle Keramidas,Valérie Edmond,J.L. Coll,Christian Brambilla,Elisabeth Brambilla,Sylvie Gazzeri,Beatrice Eymin

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

2010

G. Merdzhanova
Stéphanie Gout
Michelle Keramidas
Valérie Edmond
J.L. Coll
Christian Brambilla
Elisabeth Brambilla
Sylvie Gazzeri
Beatrice Eymin

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

Keywords:

SR protein
Transcription factor
Cancer research
Gene isoform
In vivo
Vascular endothelial growth factor A
Molecular biology
Neovascularization
Biology
E2F1
Growth factor receptor
Cell cycle

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations